Lercan(Lercanidipine-Omniapharm)
20 mg, coated tablets
Lercanidipine hydrochloride
Lercan and Lercanidipine-Omniapharm are different trade names for the same drug.
Lercan contains the active substance lercanidipine hydrochloride, which belongs to a group of medicines called calcium antagonists (dihydropyridine derivatives), which lower blood pressure.
Lercan is used to treat mild to moderate hypertension (high blood pressure) in adults over 18 years of age (the drug is not recommended for use in children under 18 years of age).
Before starting to take Lercan, discuss it with your doctor or pharmacist:
Tell your doctor about pregnancy, suspected pregnancy, or planning pregnancy, as well as breastfeeding (see "Pregnancy, breastfeeding, and fertility").
The safety and efficacy of Lercan in children under 18 years of age have not been established.
Tell your doctor or pharmacist about all medicines you are taking now or have taken recently, as well as any medicines you plan to take. This is because if Lercan is taken with other medicines, its effect or the effect of other medicines may change, and certain side effects may occur more frequently (see also section 2, subsection "When not to take Lercan").
In particular, tell your doctor or pharmacist if you are taking any of the following medicines:
Lercan is not recommended if you are pregnant. Do not take it during breastfeeding. There is no data on the use of Lercan in pregnant or breastfeeding women. If you are pregnant or breastfeeding, or if you do not use any contraceptive method, suspect you may be pregnant, or plan to have a child, consult your doctor or pharmacist before taking this medicine.
If you experience dizziness or drowsiness while taking this medicine, do not drive or operate machinery.
If you have previously been diagnosed with intolerance to some sugars, consult your doctor before taking the medicine.
This medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means the medicine is considered "sodium-free".
Always take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
Lercan is available in the following strengths: 10 mg, 20 mg.
Adults:
Use in children and adolescents
Elderly:
Patients with liver or kidney impairment:
Do not take more than the recommended dose.
If you have taken more than the recommended dose, contact your doctor or go to the emergency department of the nearest hospital immediately. Take the medicine packaging with you.
Taking more than the recommended dose of Lercan may cause excessive lowering of blood pressure and irregular or rapid heart rate.
If you forget to take a dose of Lercan, skip the missed dose and take the next dose the next day according to the established schedule. Do not take a double dose to make up for the missed dose.
If you stop taking Lercan, your blood pressure may rise again.
Before stopping treatment, consult your doctor.
If you have any further doubts about taking this medicine, consult your doctor or pharmacist.
Like all medicines, Lercan can cause side effects, although not everybody gets them.
The following side effects may occur when taking Lercan:
Rarely (may occur in less than 1 in 1000 people): angina pectoris (e.g., chest pain caused by insufficient blood flow to the heart), allergic reactions (symptoms include itching, rash, hives), fainting.
In patients with pre-existing angina pectoris, the frequency, duration, or severity of angina attacks may increase during treatment with medicines of the same class as Lercan. In rare cases, myocardial infarction may occur.
Common (may occur in less than 1 in 10 people): headache, rapid heart rate, feeling of rapid or irregular heart rate (palpitations), sudden reddening of the face, neck, or upper chest (flushing), swelling of the ankles.
Uncommon (may occur in less than 1 in 100 people): dizziness, low blood pressure, heartburn, nausea, stomach pain, skin rash, itching, muscle pain, frequent urination, weakness, fatigue.
Rare (may occur in less than 1 in 1000 people): drowsiness, vomiting, diarrhea, hives, increased urination, chest pain.
Frequency not known (frequency cannot be estimated from the available data): gum swelling, liver function disorders (detected in blood tests), clouding of the fluid (during dialysis with a catheter placed in the abdominal cavity), swelling of the face, lips, tongue, or throat, which may cause difficulty breathing or swallowing.
If you experience any side effects, including those not listed in the leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Adverse Reaction Monitoring of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the carton. The expiry date refers to the last day of the month.
Store in the original packaging to protect from light.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Lercan is pink, round, biconvex, coated tablets with a diameter of 8.5 mm and a score line on one side.
Lercan is available in packs containing 28 or 56 coated tablets in aluminum/PVC blisters, in a cardboard box.
For more detailed information, consult the marketing authorization holder or the parallel importer.
Recordati Pharma GmbH
Eberhard-Finckh-Str. 55
89075 Ulm
Germany
Recordati S.p.A. Industria Chimica e Farmaceutica
Via Matteo Civitali 1
I-20148 Milan
Italy
Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź
Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź
CEFEA Sp. z o.o. Sp. komandytowa
ul. Działkowa 56
02-234 Warsaw
CANPOLAND SPÓŁKA AKCYJNA
ul. Beskidzka 190
91-610 Łódź
Laboratorium Galenowe Olsztyn Sp. z o.o.
ul. Spółdzielcza 25A
11-001 Dywity
Pharma Innovations Sp. z o. o.
ul. Jagiellońska 76
03-301 Warsaw
IVA Pharm Sp. z o.o.
ul. Drawska 14/1
02-202 Warsaw
Marketing authorization number in Germany, the country of export: 65406.00.00
Parallel import authorization number: 248/18
Date of leaflet approval: 17.04.2023
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.